Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis
- PMID: 17325294
- DOI: 10.1001/archinte.167.4.335
Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis
Abstract
Background: There is no consensus whether tobacco smoking increases risk of tuberculosis (TB) infection, disease, or mortality. Whether this is so has substantial implications for tobacco and TB control policies.
Objective: To quantify the relationship between active tobacco smoking and TB infection, pulmonary disease, and mortality using meta-analytic methods.
Methods: Eight databases (PubMed, Current Contents, BIOSIS, EMBASE, Web of Science, Centers for Disease Control and Prevention Tobacco Information and Prevention Source [TIPS], Smoking and Health Database [Institute for Science and Health], and National Library of Medicine Gateway) and the Cochrane Tobacco Addiction Group Trials Register were searched for relevant articles published between 1953 and 2005.
Study selection: Included were epidemiologic studies that provided a relative risk (RR) estimate for the association between TB (infection, pulmonary disease, or mortality) and active tobacco smoking stratified by (or adjusted for) at least age and sex and a corresponding 95% confidence interval (CI) (or data for calculation). Excluded were reports of extrapulmonary TB, studies conducted in populations prone to high levels of smoking or high rates of TB, and case-control studies in which controls were not representative of the population that generated the cases, as well as case series, case reports, abstracts, editorials, and literature reviews.
Data extraction: Twenty-four studies were included in the meta-analysis. Extracted data included study design, population and diagnostic details, smoking type, and TB outcomes.
Data synthesis: A random-effects model was used to pool data across studies. Separate analyses were performed for TB infection (6 studies), TB disease (13 studies), and TB mortality (5 studies). For TB infection, the summary RR estimate was 1.73 (95% CI, 1.46-2.04); for TB disease, estimates ranged from 2.33 (95% CI, 1.97-2.75) to 2.66 (95% CI, 2.15-3.28). This suggests an RR of 1.4 to 1.6 for development of disease in an infected population. The TB mortality RRs were mostly below the TB disease RRs, suggesting no additional mortality risk from smoking in those with active TB.
Conclusions: The meta-analysis produced evidence that smoking is a risk factor for TB infection and TB disease. However, it is not clear that smoking causes additional mortality risk in persons who already have active TB. Tuberculosis control policies should in the future incorporate tobacco control as a preventive intervention.
Comment in
-
Smoking and tuberculosis: infection, disease, and mortality.Arch Intern Med. 2007 Oct 8;167(18):2008-9; author reply 2009. doi: 10.1001/archinte.167.18.2008-b. Arch Intern Med. 2007. PMID: 17923605 No abstract available.
-
Smoking and risk of tuberculosis.Arch Intern Med. 2007 Oct 8;167(18):2008; author reply 2009. doi: 10.1001/archinte.167.18.2008-a. Arch Intern Med. 2007. PMID: 17923606 No abstract available.
Similar articles
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 Jan 8;1:CD010216. doi: 10.1002/14651858.CD010216.pub8. PMID: 36384212 Free PMC article. Updated.
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Nov 17;11:CD010216. doi: 10.1002/14651858.CD010216.pub7. PMID: 34519354 Free PMC article. Updated.
-
Heated tobacco products for smoking cessation and reducing smoking prevalence.Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2. Cochrane Database Syst Rev. 2022. PMID: 34988969 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Strategies to improve smoking cessation rates in primary care.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693994 Free PMC article.
Cited by
-
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.Bull World Health Organ. 2013 Jan 1;91(1):36-45. doi: 10.2471/BLT.12.104588. Epub 2012 Nov 26. Bull World Health Organ. 2013. PMID: 23397349 Free PMC article.
-
Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study.Pulm Med. 2012;2012:828106. doi: 10.1155/2012/828106. Epub 2012 Dec 10. Pulm Med. 2012. PMID: 23304497 Free PMC article.
-
Smoking and HIV: prevalence, health risks, and cessation strategies.Curr HIV/AIDS Rep. 2012 Sep;9(3):223-30. doi: 10.1007/s11904-012-0121-0. Curr HIV/AIDS Rep. 2012. PMID: 22618079 Review.
-
Population benefits of addressing programmatic and social determinants of gender disparities in tuberculosis in Viet Nam: A modelling study.PLOS Glob Public Health. 2022 Jul 14;2(7):e0000784. doi: 10.1371/journal.pgph.0000784. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962475 Free PMC article.
-
Tuberculosis: evidence review for newly arriving immigrants and refugees.CMAJ. 2011 Sep 6;183(12):E939-51. doi: 10.1503/cmaj.090302. Epub 2010 Jul 15. CMAJ. 2011. PMID: 20634392 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical